NetApp partners with Supermicro on validated AI infrastructure solutions
Bitget2026/09/29 17:30Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- NetApp entered a strategic collaboration with Supermicro to deliver jointly validated AI infrastructure spanning AI factories, enterprises, neoclouds, sovereign AI.
- Joint offering pairs Supermicro AI-optimized compute with the NetApp Platform to speed deployments, lift GPU utilization, strengthen data governance.
- Initial implementation runs NetApp Novus Data Director on qualified Supermicro servers with NetApp AFF A90 as the ONTAP data layer.
- Architecture targets independent scaling of compute and data, aiming to cut integration time, lower deployment risk, reduce operating complexity.
- Companies will also support a private AI platform, NetApp AIPod with Supermicro, aligned to NVIDIA Enterprise Reference Architecture guidance.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. NetApp Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609291330BIZWIRE_USPR_____20260929_BW239339) on September 29, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
Former BioNTech executive leads Bambusa Therapeutics (BBTX.US) in sprint to Nasdaq, "boosting" eczema drug trials
Bambusa Therapeutics Inc. has filed for an initial public offering, planning to raise funds for clinical trials of treatments for eczema and other inflammatory diseases.
智通财经•2026/10/10 06:21
JPMorgan raises AbbVie target price to $300
格隆汇•2026/10/10 05:29
Crypto prices
MoreBitcoin
BTC
$82,726.3
+0.29%
Ethereum
ETH
$2,492.49
-0.10%
Tether USDt
USDT
$0.9992
+0.00%
BNB
BNB
$748.04
+0.68%
XRP
XRP
$1.41
+0.48%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$109.81
-0.70%
TRON
TRX
$0.3305
-0.43%
Hyperliquid
HYPE
$84.14
-1.75%
Zcash
ZEC
$1,222.92
-0.04%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now